126 related articles for article (PubMed ID: 1587349)
1. Up-regulation of interleukin (IL)-6 receptor gene expression in vitro and in vivo in IL-6 deprived myeloma cells.
Portier M; Lees D; Caron E; Jourdan M; Boiron JM; Bataille R; Klein B
FEBS Lett; 1992 May; 302(1):35-8. PubMed ID: 1587349
[TBL] [Abstract][Full Text] [Related]
2. Increase in interleukin 6 (IL-6) and IL-6 receptor expression in a human multiple myeloma cell line, U-266, during long-term in vitro culture and the development of a possible autocrine IL-6 loop.
Jernberg-Wiklund H; Pettersson M; Carlsson M; Nilsson K
Leukemia; 1992 Apr; 6(4):310-8. PubMed ID: 1588793
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity in response to interleukin 6 (IL-6), expression of IL-6 and IL-6 receptor mRNA in a panel of established human multiple myeloma cell lines.
Jernberg H; Pettersson M; Kishimoto T; Nilsson K
Leukemia; 1991 Mar; 5(3):255-65. PubMed ID: 1707469
[TBL] [Abstract][Full Text] [Related]
4. Acquisition of growth autonomy and tumorigenicity by an interleukin 6-dependent human myeloma cell line transfected with interleukin 6 cDNA.
Okuno Y; Takahashi T; Suzuki A; Fukumoto M; Nakamura K; Fukui H; Koishihara Y; Ohsugi Y; Imura H
Exp Hematol; 1992 May; 20(4):395-400. PubMed ID: 1568457
[TBL] [Abstract][Full Text] [Related]
5. Role of interleukin-6 in the proliferation of human multiple myeloma cell lines OCI-My 1 to 7 established from patients with advanced stage of the disease.
Hitzler JK; Martinez-Valdez H; Bergsagel DB; Minden MD; Messner HA
Blood; 1991 Oct; 78(8):1996-2004. PubMed ID: 1912582
[TBL] [Abstract][Full Text] [Related]
6. The IL-6 gene but not the IL-6 receptor gene is occasionally rearranged in patients with multiple myeloma.
Fiedler W; Weh HJ; Suciu E; Wittlief C; Stocking C; Hossfeld DK
Leukemia; 1990 Jul; 4(7):462-5. PubMed ID: 1695702
[TBL] [Abstract][Full Text] [Related]
7. gamma-Interferon in multiple myeloma: inhibition of interleukin-6 (IL-6)-dependent myeloma cell growth and downregulation of IL-6-receptor expression in vitro.
Portier M; Zhang XG; Caron E; Lu ZY; Bataille R; Klein B
Blood; 1993 Jun; 81(11):3076-82. PubMed ID: 8499642
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid modulates the in vivo and in vitro growth of IL-6 autocrine human myeloma cell lines via induction of apoptosis.
Levy Y; Labaume S; Colombel M; Brouet JC
Clin Exp Immunol; 1996 Apr; 104(1):167-72. PubMed ID: 8603522
[TBL] [Abstract][Full Text] [Related]
9. Role of interleukin 16 in multiple myeloma.
Atanackovic D; Hildebrandt Y; Templin J; Cao Y; Keller C; Panse J; Meyer S; Reinhard H; Bartels K; Lajmi N; Sezer O; Zander AR; Marx AH; Uhlig R; Zustin J; Bokemeyer C; Kröger N
J Natl Cancer Inst; 2012 Jul; 104(13):1005-20. PubMed ID: 22745469
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of inhibition of IL-6-mediated immunoglobulin secretion by dexamethasone and suramin in human lymphoid and myeloma cell lines.
Shiao RT; McLeskey SB; Khera SY; Wolfson A; Freter CE
Leuk Lymphoma; 1996 Apr; 21(3-4):293-303. PubMed ID: 8726410
[TBL] [Abstract][Full Text] [Related]
11. The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment.
Giuliani N; Colla S; Morandi F; Rizzoli V
Haematologica; 2004 Sep; 89(9):1118-23. PubMed ID: 15377473
[TBL] [Abstract][Full Text] [Related]
12. Role of interleukin 6 in the growth of myeloma-derived cell lines.
Barut BA; Zon LI; Cochran MK; Paul SR; Chauhan D; Mohrbacher A; Fingeroth J; Anderson KC
Leuk Res; 1992 Oct; 16(10):951-9. PubMed ID: 1405708
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of the interleukin-6-signal transducing protein (gp130) by interleukin-6 and dexamethasone in HepG2 cells.
Schooltink H; Schmitz-Van de Leur H; Heinrich PC; Rose-John S
FEBS Lett; 1992 Feb; 297(3):263-5. PubMed ID: 1544406
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
Tassone P; Neri P; Burger R; Savino R; Shammas M; Catley L; Podar K; Chauhan D; Masciari S; Gozzini A; Tagliaferri P; Venuta S; Munshi NC; Anderson KC
Clin Cancer Res; 2005 Jun; 11(11):4251-8. PubMed ID: 15930364
[TBL] [Abstract][Full Text] [Related]
15. IFN-alpha induces autocrine production of IL-6 in myeloma cell lines.
Jourdan M; Zhang XG; Portier M; Boiron JM; Bataille R; Klein B
J Immunol; 1991 Dec; 147(12):4402-7. PubMed ID: 1753108
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1.
Jourdan M; De Vos J; Mechti N; Klein B
Cell Death Differ; 2000 Dec; 7(12):1244-52. PubMed ID: 11175262
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells.
Hata H; Xiao H; Petrucci MT; Woodliff J; Chang R; Epstein J
Blood; 1993 Jun; 81(12):3357-64. PubMed ID: 8507873
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of interleukin-6 receptors by interleukin-6 and interferons in multiple myeloma cell lines.
Lasfar A; Wietzerbin J; Billard C
Eur J Immunol; 1994 Jan; 24(1):124-30. PubMed ID: 8020547
[TBL] [Abstract][Full Text] [Related]
19. Roles of protein phosphatase 1 and 2A in an IL-6-mediated autocrine growth loop of human myeloma cells.
Kang HS; Lee BS; Yang Y; Park CW; Ha HJ; Pyun KH; Choi I
Cell Immunol; 1996 Mar; 168(2):174-83. PubMed ID: 8640863
[TBL] [Abstract][Full Text] [Related]
20. IL-6 upregulates its own receptor on some human myeloma cell lines.
Thabard W; Collette M; Mellerin MP; Puthier D; Barillé S; Bataille R; Amiot M
Cytokine; 2001 Jun; 14(6):352-6. PubMed ID: 11497497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]